Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novogen Announces FDA Approves IND Application for Cantrixil in Ovarian Cancer
Novogen Announces FDA Approves IND Application for Cantrixil in Ovarian Cancer
Novogen Announces FDA Approves IND Application for Cantrixil in Ovarian Cancer
Submitted by
admin
on September 12, 2016 - 9:24am
Source:
Yahoo/Benzinga
News Tags:
Novogen
FDA
Cantrixil
ovarian cancer
Headline:
Novogen Announces FDA Approves IND Application for Cantrixil in Ovarian Cancer
Do Not Allow Advertisers to Use My Personal information
